Omaglip 12.5 mg Tablet Uses, Dosage, Side Effects and more
Omaglip 12.5 mg Tablet has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
| Attribute | Details |
|---|---|
| Trade Name | Omaglip 12.5 mg Tablet |
| Generic | Omarigliptin |
| Omarigliptin Other Names | Omarigliptin |
| Weight | 12.5 mg |
| Type | Tablet |
| Formula | C17H20F2N4O3S |
| Weight | Average: 398.43 Monoisotopic: 398.12241802 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Navana Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | January 7, 2025 at 1:49 am |
